DDDandan Dong

Dandan Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dandan Dong has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Guangqing Liu

    Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Shanghai, 200241, China

    2 shared publications
  • Jie Zhu

    Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China

    2 shared publications
  • Qiuhong Miao

    Innovation Team of Small Animal Infectious Disease, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China

    2 shared publications
  • Ruibin Qi

    Innovation Team of Small animal Infectious Disease, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China

    2 shared publications
  • Aoxing Tang

    Innovation Team of Small animal Infectious Disease, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China

    1 shared publication
  • Dongdong Yin

    Innovation Team of Small animal Infectious Disease, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China

    1 shared publication

Latest Publications

  • Open Access

    Novel IncR/IncP6 Hybrid Plasmid pCRE3-KPC Recovered from a Clinical KPC-2-Producing Citrobacter braakii Isolate

    by Dandan Dong, Ziqiang Mi, Dujun Li, Mingming Gao, Nan Jia, Manli Li, Yigang Tong, Xianglilan Zhang, Yuanqi Zhu

    Reports of human-pathogenic C. braakii strains, especially of strains showing resistance to carbapenems, are rare. To the best of our knowledge, our results represent the first detection of carbapenemase gene bla KPC-2 in C. braakii strains. In addition, we have studied detailed genetic characteristics of the novel IncR/IncP6 hybrid plasmid pCRE3-KPC, which was isolated from a clinical multidrug-resistant Citrobacter braakii CRE3 strain. Our results may provide further insight into the horizontal transfer of multidrug resistance genes in bacteria and into the genomic diversity and molecular evolution of plasmids.


  • Open Access

    Nucleolin (NCL) inhibits the growth of peste des petits ruminants virus

    by Dandan Dong, Shiqiang Zhu, Qiuhong Miao, Jie Zhu, Aoxing Tang, Ruibin Qi, Teng Liu, Dongdong Yin, Guangqing Liu

    Peste des petits ruminants (PPR) is a highly contagious disease of small ruminants that is caused by peste des petits ruminants virus (PPRV). To date, the molecular mechanism of PPRV infection is still unclear. It is well known that host proteins might be involved in the pathogenesis process for many viruses. In this study, we first proved that nucleolin (NCL), a highly conserved host factor, interacts with the core domain of PPRV N protein through its C terminus and co-locates with the N protein in the nucleus of cells. To investigate the role of NCL in PPRV infection, the expression level of NCL was inhibited with small interfering RNAs of NCL, and the results showed that PPRV growth was improved. However, the proliferation of PPRV was inhibited when the expression level of NCL was improved. Further analysis indicated that the inhibitory effect of NCL on the PPRV was caused by stimulating the interferon (IFN) pathways in host cells. In summary, our results will help us to understand the mechanism of PPRV infection.


  • Open Access

    Nucleolin mediates the internalization of rabbit hemorrhagic disease virus through clathrin-dependent endocytosis

    by Jie Zhu, Qiuhong Miao, Jingyu Tang, Xiaoxue Wang, Dandan Dong, Teng Liu, Ruibin Qi, Zhibiao Yang, Guangqing Liu

    Rabbit hemorrhagic disease virus (RHDV) is an important member of the Caliciviridae family and a highly lethal pathogen in rabbits. Although the cell receptor of RHDV has been identified, the mechanism underlying RHDV internalization remains unknown. In this study, the entry and post-internalization of RHDV into host cells were investigated using several biochemical inhibitors and RNA interference. Our data demonstrate that rabbit nucleolin (NCL) plays a key role in RHDV internalization. Further study revealed that NCL specifically interacts with the RHDV capsid protein (VP60) through its N-terminal residues (aa 285–318), and the exact position of the VP60 protein for the interaction with NCL is located in a highly conserved region (472Asp-Val-Asn474; DVN motif). Following competitive blocking of the interaction between NCL and VP60 with an artificial DVN peptide (RRTGDVNAAAGSTNGTQ), the internalization efficiency of the virus was markedly reduced. Moreover, NCL also interacts with the C-terminal residues of clathrin light chain A, which is an important component in clathrin-dependent endocytosis. In addition, the results of animal experiments also demonstrated that artificial DVN peptides protected most rabbits from RHDV infection. These findings demonstrate that NCL is involved in RHDV internalization through clathrin-dependent endocytosis. Rabbit hemorrhagic disease virus (RHDV) is the causative agent of a highly contagious and lethal disease in rabbits. Since, at present, there is no robust cell culture system for the propagation of the virus, the molecular mechanism of RHDV internalization remains poorly understood. Here, we demonstrated that rabbit nucleolin (NCL) efficiently mediates RHDV internalization by interacting with the RHDV capsid protein (VP60). The exact function domains of the interaction between NCL and VP60 were also determined. Notably, these functional domains are highly conserved in all RHDV genotypes. Further study results revealed that NCL was involved in clathrin-dependent endocytosis through interactions with the C-terminal residues of clathrin light chain A. In addition, the artificial peptide (RRTGDVNAAAGSTNGTQ; DVN peptide) based on the functional domain, which is responsible for RHDV VP60 binding to NCL, is able to inhibit RHDV infection, indicating that the DVN peptide might be a candidate target for the design of antiviral drugs against RHDV infection.